These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19022316)

  • 1. Technology transfer hub for pandemic influenza vaccine.
    Friede M; Serdobova I; Palkonyay L; Kieny MP
    Vaccine; 2009 Jan; 27(5):631-2. PubMed ID: 19022316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international technology platform for influenza vaccines.
    Hendriks J; Holleman M; de Boer O; de Jong P; Luytjes W
    Vaccine; 2011 Jul; 29 Suppl 1():A8-11. PubMed ID: 21684431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer.
    Miyaki C; Meros M; Precioso AR; Raw I
    Vaccine; 2011 Jul; 29 Suppl 1():A12-5. PubMed ID: 21684420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future.
    LaForce FM
    Vaccine; 2011 Jul; 29 Suppl 1():A1. PubMed ID: 21684419
    [No Abstract]   [Full Text] [Related]  

  • 10. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza: imminent threat, preparedness and the divided globe.
    Chaturvedi S
    Indian Pediatr; 2009 Feb; 46(2):115-21. PubMed ID: 19242025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swine flu pandemic. Developing countries to get some H1N1 vaccine--but when?
    Enserink M
    Science; 2009 Nov; 326(5954):782. PubMed ID: 19892952
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO influenza vaccine technology transfer initiative: role and activities of the Technical Advisory Group.
    Francis DP; Grohmann G
    Vaccine; 2011 Jul; 29 Suppl 1():A45-7. PubMed ID: 21684429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic fears hatch new methods in flu vaccine industry.
    Singer E
    Nat Med; 2005 Jan; 11(1):4. PubMed ID: 15635422
    [No Abstract]   [Full Text] [Related]  

  • 16. Domestic influenza vaccine production in Mexico: a state-owned and a multinational company working together for public health.
    Ponce-de-Leon S; Velazquez-Fernandez R; Bugarin-González J; García-Bañuelos P; Lopez-Sotelo A; Jimenez-Corona ME; Padilla-Catalan F; Cervantes-Rosales R
    Vaccine; 2011 Jul; 29 Suppl 1():A26-8. PubMed ID: 21684424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of pandemic influenza vaccine production capacity in Viet Nam.
    Hoa LK; Hiep LV; Be LV
    Vaccine; 2011 Jul; 29 Suppl 1():A34-6. PubMed ID: 21684426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
    Mylius SD; Hagenaars TJ; Lugnér AK; Wallinga J
    Vaccine; 2008 Jul; 26(29-30):3742-9. PubMed ID: 18524428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.